In this episode of "View from the Thoraxcenter," Prof Nicolas Van Mieghem and Dr Joost Daemen preview the most anticipated late-breaking and featured science trials of ACC.23 and discuss their potential impact on patient care and research. The trials covered include structural interventions such as TRILUMINATE Pivotal, UK Mini Mitral, COAPT, and Evolut Low Risk, as well as coronary interventions including REVIVED-BCIS2, RENOVATE-COMPLEX-PCI, and BIOVASC. Additionally, they cover trials related to statins, including Yellow III, CLEAR Outcomes, and MK-0616. Tune in for the latest developments in cardiology research.